Abstract
In this month’s edition, Hay et al present their analysis of the impact of radioactive iodine remnant ablation (RRA) in low risk adult papillary thyroid carcinoma (PTC). With a median follow up of 13.8 years, and a total of over 50,000 patient-years of follow-up, they find that RRA did not reduce either cause specific mortality or recurrence rate, and therefore they don’t recommend RRA in low risk adult patients with PTC who undergo bilateral lobar resection with curative intent.
Original language | English |
---|---|
Pages (from-to) | 1700-1702 |
Number of pages | 3 |
Journal | Mayo Clinic Proceedings |
Volume | 96 |
Issue number | 7 |
DOIs | |
Publication status | Published - 1 Jul 2021 |